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Abstract
Background: Left ventricular (LV) contractility impairment in coronary artery disease pa-
tients may be the effect of heart muscle hibernation due to chronic ischemia. Revascularization
is the only method to restore contractile function in these patients. The time and degree of LV
function improvement have not been precisely determined, and the published data are discord-
ant. The aim of our study was to evaluate the time of myocardial contractility recovery after
surgical revascularization in patients with systolic LV dysfunction in relation to the results of
echocardiography stress tests.
Methods: The study included 50 patients with multivessel coronary artery disease and de-
creased left ventricular ejection fraction (LVEF < 40%) qualified for coronary artery by-pass
grafting. The intervention was preceded by rest echocardiography, low dose dobutamine stress
test (510 µg/kg/min) and by low dose dipyridamole stress test (0.24 mg/kg during 4 min)
performed on the next day. Consecutive rest echocardiograms were performed immediately
after the intervention and after 3, 6 and 12 months. LVEF and the index of left ventricular
contractility (WMSI, wall motion score index) were evaluated at each examination.
Results: During 1-year follow-up after coronary artery by-pass grafting (CABG), significant
improvement in LV systolic function was observed (LVEF increased, WSMI reduced), with
major changes occurring over the first 6 months. The correlation of echocardiography param-
eters (EF, WMSI) at stress tests and during 1-year follow-up showed that the strongest rela-
tionship exists between the change in WMSI both in dobutamine and dipyridamole stress tests
and the improvement in WMSI observed after 6 months.
Conclusions: LV function improvement after CABG in patients with systolic LV dysfunction
was most pronounced 3 to 6 months after the intervention. Both types of stress tests are character-
ized by similar diagnostic value for assessing LV myocardial viability. WMSI calculated during
stress was identified to have the strongest prognostic value. (Cardiol J 2007; 14: 246251)
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Introduction
Surgical myocardial revascularization (CABG,
coronary artery by-pass grafting) brings most ben-
efit to those patients, in whom left ventricular dys-
function related to coronary artery disease is the
effect of chronic heart muscle hibernation [1].
According to Braunwald and Rutherford, heart mus-
cle hibernation is defined by the decrease of con-
tractility caused by prolonged reduction of coronary
blood flow. During prolonged ischemia, the coro-
nary blood flow is usually sufficient for the survival
of myocytes, while being insufficient to fully pro-
vide for metabolic requirements related to the con-
traction [2]. Contractility impairment can only be
reversed by the means of revascularization [3]. It
is important to note that the return to the normal
or quasi-normal state is possible [4]. The time need-
ed for left ventricular function improvement de-
pends on the degree of degenerative changes and
connective tissue proliferation [5]. The time and
degree of improvement have not been precisely
determined. Few papers discussing the above is-
sues have been published, providing inconsistent
assessment of dysfunction reversal after CABG [6].
The progress of heart muscle viability assess-
ment techniques permits a better selection of pa-
tients with coronary artery disease and associated
left ventricular dysfunction for cardiosurgical treat-
ment. Moreover, in patients with areas of viable
myocardium a much smaller degree of unfavorable
left ventricular remodeling is observed after revas-
cularization [7].
Diagnostic tests assessing heart muscle viabil-
ity have therefore become an important element in
qualifying patients for by-pass grafting, especially
in the case of low left ventriclular ejection fraction
(LVEF), since the presence of contractility disor-
ders in rest echocardiography does not necessarily
point to the permanence of the lesion. Viability as-
sessment combined with clinical presentation and
the evaluation of coronary vessel status is presently
the basis for choosing the optimum treatment. Do-
butamine and dipyridamole stress echocardiography
are used to assess myocardial viability, being both
inexpensive and relatively easily accessible meth-
ods. Studies comparing the values of both tests for
the evaluation of LV systolic function recovery af-
ter CABG are scarce.
The aim of this study was to assess the time
of heart muscle contractility recovery after revas-
cularization in patients with left ventricular systo-
lic dysfunction in relation to the results of both
tests.
Methods
Patient characteristics
The study included 50 patients (42 men and
8 women; mean age of 60 years) who were operated
in the Clinical Department of Cardiac Surgery of the
Medical University of Bia‡ystok over the period of
May 2002  February 2004. All the patients fulfilled
the following criteria:
 chronic, stable coronary disease;
 diminished left ventricular systolic function
found in echocardiography: LVEF < 40% (con-
firmed by ventriculography);
 qualification for CABG;
 lack of hemodynamically significant accompa-
nying valvular disease;
 presence of adequate technical conditions per-
mitting the performance of stress tests.
The study protocol has been accepted by the
local Bioethics Committee of the Medical Univer-
sity. The stage of heart failure was evaluated using
the New York Heart Association (NYHA) classifi-
cation according to commonly accepted criteria. The
clinical advancement of coronary artery disease was
evaluated using the Canadian Cardiovascular Soci-
ety (CCS) classification. Basic demographic data and
clinical characteristics of the investigated group are
presented in Table 1.
All the patients underwent coronary angiogra-
phy with ventriculography for clinical indications
and were subsequently qualified for surgical revas-
cularization due to the presence of multivessel dis-
ease (according to current Polish Cardiac Society
Table 1. Patient characteristics.
Mean age (years) 60 – 9 (min. 39; max. 75)
Body weight [kg] 82 – 13
Height [cm] 171 – 7
Body mass index 28 – 4 (min. 21; max. 36)
Duration of CAD Mean 6.5 (min. 3 months;
[years] max. 20 years)
History of myocardial infarct  All studied patients
Arterial hypertension 20 patients/40%
Diabetes 11/22%
Dyslipidemia 36/72%
Smoking 24/48%
Family history of CAD 29/58%
NYHA class Mean III – I
CCS class Mean 3 – 1
Left ventricular 34% – 4%
ejection fraction
Number of changed All patients: 3 vessels
coronary vessels
CAD  coronary artery disease
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guidelines). A complete coronary revascularization
was performed in all the patients. Patients were also
administered the usual pharmacological treatment,
according to current guidelines.
Study design
Rest echocardiography. Two-dimensional
transthoracic examination determining the classic
parameters according to the American Society of
Echocardiography guidelines, was performed 35
days before the coronary artery by-pass grafting.
Left ventricular contractility was assessed by ana-
lyzing the systolic increase in wall thickness, em-
ploying a division into 16 segments [3]. Wall mo-
tion score index (WMSI) was determined, assign-
ing to each of the segments of the left ventricle
a number of points corresponding to the visual as-
sessment of contractility, i.e.: 1) normokinesis (nor-
mal contractility), 2) hypokinesis (diminished systo-
lic wall thickness increase), 3) akinesis (absence of
systolic wall thickness increase), 4) dysknesis (cen-
trifugal wall movement). The WMSI was calculat-
ed by summing up the points assigned to individual
segments and by dividing the sum by the number
of segments. LVEF was calculated in a two-dimen-
sional presentation, employing the biplane Simp-
sons method and calculating the mean value from
three consecutive heart cycles. The two parame-
ters were assessed both during rest echocardiog-
raphy and in stress tests.
Follow-up examinations were performed dur-
ing hospitalization, in the first week following by-
pass grafting and at 3, 6 and 12 months after the
intervention.
Echocardiography stress tests. Dobutamine
test. The patients were administered no drugs with
a positive inotropic effect during the 3 days preced-
ing the examination. The test with low dose dob-
utamine (510 µg/kg/min) was performed 34 days
before the operation. After recording the standard
projections in a rest examination (parasternal long
and short axis projections, apical 2- and 4-chamber
projections), intravenous dobutamine infusion was
administered. Recording on a magnetooptic disk
started 6 min after the infusion was initiated. Heart
rate and arterial blood pressure were monitored
during the test and for 10 minutes after it was fin-
ished. Criteria for interrupting the test were:
a decrease in arterial blood pressure of at least 10%,
chest pain, increasing dyspnea, significant
supraventricular and ventricular arrhythmia.
Dipyridamole test. The patients consumed no
caffeine-containing products and discontinued any
theophylline-derived drugs during the 24 hours
preceding the examination. The test with a small
dose of dipyridamole was performed 34 days be-
fore the operation, on the day following the dob-
utamine test. Similar to the case of dobutamine,
after recording the four standard parameters in
a rest examination, 0.28 mg/kg of dipyridamole was
administered during 4 min in an intravenous infu-
sion. Recording on a magnetooptic disk and a video
tape started 4 min after the infusion was initiated.
All the above mentioned standard projections were
documented. Heart rate and arterial blood pressure
were monitored during the test and for 10 min
afterwards. Criteria for interrupting the test were:
appearance of a chest pain, ventricular ectopic
beats, arterial blood pressure decrease and ST
change.
Left ventricular contractility was assessed by
analyzing the systolic increase in wall thickness and
LVEF changes. Both parameters were assessed at
rest after completing the dobutamine and dipyrida-
mole tests. Rest echocardiography images record-
ed before CABG, evaluating baseline left ventricu-
lar contractility disorders, were compared to imag-
es recorded 56 days after the operation and after
3, 6 and 12 months. All tests were performed by an
experienced echocardiographist.
Heart muscle viability was defined as an in-
crease in wall contractility of at least 1 point in the
4 points scale. Viability assessment was performed
during the examination by comparing the stress test
and the baseline test recordings.
All patients obtained the usual treatment for
coronary artery disease, according to current stand-
ards.
Statistical analysis
Data distribution was checked with the
Ko‡mogorow-Smirnow test. For qualitative varia-
bles, data are presented as quantitative and per-
centage distribution, and for continuous variables
as mean value – standard deviation and the mini-
mum and maximum values within the investigat-
ed group. Mean value from three consecutive
measurements was used for echocardiography
analysis. T-test for dependent and independent
paired samples or the Wilcoxon test was used for
analysis. The correlation index reflecting the de-
gree of relationship between data sets was calcu-
lated using the Pearson or Spearman method, de-
pending on the type of variables. Results were
considered statistically significant when the varia-
bility level was < 0.05. Calculations were per-
formed using a MEDCALC 8.1.0.0 statistical
program (Frank Schoonjans 2005).
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Results
Echocardiography assessment
Before the operation. Table 2 presents ejec-
tion fraction and left ventricular contractility in-
dex values at baseline and after dobutamine and
dipyridamole stress tests. A similar improvement
in LVEF and WMSI was noted after both tests:
baseline EF value was of 33.7% – 4.1%, after do-
butamine administration it increased to 41.0% –
– 5.6% (p < 0.0001), and after dipyridamole stress
test it increased to 40.3% – 5.1% (p < 0.0001);
WMSI value before revascularization was of 1.96 –
– 0.19, after dobutamine it diminished to 1.59 –
– 0.23 (p < 0.0001), and after dipyridamole to 1.63 –
– 0.24 (p < 0.0001).
After the operation. Directly following
CABG, mean EF value increased slightly and was
of 35.2% – 4.1% (from baseline 33.7% – 4.1%). At
3 months from the operation a further increase to
37.8% – 5.1% (p = 0.0002) was observed. It was
rising over the following months to attain 38.9% –
– 5.3% (p < 0.0001) at 6 months. At 1 year from
the intervention, EF value was of 39.6% – 5.6%
(p < 0.0001 in relation to baseline values). The dif-
ferences after 6 months and 1 year from the opera-
tion were not statistically significant. They were sig-
nificantly different from baseline values. Figure 1
presents the gradual improve of left ventricular
systolic function over 1-year observation period.
Baseline LV wall contractility index value was of
1.96 – 0.19. Following CABG it decreased to 1.83 –
– 0.18. Further improvement was noted after
3 months of observation, with a decrease to 1.74 –
– 0.20 (p < 0.0001). At 6 months from the intervention
WMSI reached the value of 1.66 – 0.22 (p < 0.0001),
and at 1 year 1.60 – 0.24 (p < 0.0001). WMSI dif-
ferences compared to baseline examination were
statistically significant. Thus the surgical interven-
tion resulted in a gradual improvement of LV wall
contractility index (Fig. 2).
Both in the dopamine and dipyridamole tests,
the relation between the change in the parameter
value during stress test and its change during the
period before and after 6 months from the operation
was stronger for WMSI than for LVEF (Fig. 3, 4).
These results indicate that the largest im-
provement of left ventricular function occurred
Table 2. Left ventricular ejection fraction (LVEF) and left ventricular contractility index values (WMSI) at
baseline and after dobutamine and dipyridamole stress tests (p < 0.0001 in relation to baseline values).
Baseline After dobutamine After dipyridamole
parameters administration administration
LVEF 33.7%–4.1% 41.0%–5.6% (p < 0.0001) 40.3%–5.1% (p < 0.0001)
WMSI 1.96–0.19 1.59–0.23 (p < 0.0001) 1.63–0.24 (p < 0.0001)
Figure 1. Left ventricular ejection fraction (LVEF) during
1-year follow-up  baseline LVEF (LVEF), after corona-
ry artery bypass grafting (LVEF_1m), after 3 (LVEF_3m),
6 (LVEF_6m) and 12 (LVEF_12m) months of observation.
Figure 2. Wall motion score index (WMSI) during follow-up
 baseline WMSI (WMSI), after coronary artery bypass
grafting (WMSI_1m), after 3 (WMSI_3m), 6 (WMSI_6m)
and 12 (WMSI_12m) months of observation.
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during the first 6 months following CABG. We also
demonstrated the comparable prognostic value of
both stress tests for predicting contractility im-
provement after the intervention. Left ventricular
wall contractility index calculated after the admin-
istration of both drugs proved to have the highest
prognostic value.
Discussion
The time and degree of LV function recovery
following surgical revascularization have not been
closely investigated. Available literature provides
discordant data concerning the time of regression
of left ventricular contractility impairment due to
heart muscle hibernation [6]. Some authors report-
ed immediate contractility improvement after cor-
onary artery by-pass grafting [6]. On the other hand,
Szulczyk et al. [8] did not observe significant chang-
es in left ventricular systolic function after 3 months
from revascularization. However, Bax et al. [9] dem-
onstrated significant improvement in LVEF as well
as in NYHA and CCS class at 3 months from the in-
tervention. This concerned only the patients with vi-
able heart muscle found in at least 4 segments.
In our group of patients, maximum improvement
in LV contractility parameters was observed after
6 months from CABG. A similar time of systolic func-
tion recovery after revascularization was noted by
Soto and Beller [2] and by Pagano et al. [10]. On the
other hand, Rizzello et al. [11] observed the im-
provement in NYHA and CCS class in patients with
viability confirmed in at least 4 segments at an even
later time: 912 months from the intervention. In
view of these data, Bax [9] emphasizes with reason
that the choice of the optimum contractility assess-
ment period after CABG remains unclear. Litera-
ture data suggest that cardiomyocyte function re-
covery may be expected between 6 and 12 months
after the intervention [12, 13], or sometimes after
a much longer period of up to 4 years [14].
Differences observed in the literature may be
related to the large spectrum of metabolic disorders
occurring in the state of heart muscle hibernation.
Cardioprotective mechanisms of the hibernated
myocardium may prove insufficient in the case of
a long-lasting ischemia. This may cause irreversi-
ble morphologic changes, resulting in myocyte de-
generation and, in consequence, in a delayed or in-
complete contractility improvement [15]. It should
be assumed that the regression of LV contractility
disorders due to heart muscle hibernation depends
on the duration and degree of ischemia [5, 15]. If
myocyte degeneration process is advanced, more
time is needed for the reconstruction of the con-
tractile apparatus. It can be presumed that progress-
ing heart damage with cell necrosis, myocardial fi-
brosis and irreversible contractility disorders would
occur with no revascularization [8].
In the investigated group of patients the dura-
tion of coronary artery disease was moderately long,
with a mean value of 6.5 years. Available literature
does not provide sufficient data concerning the re-
lationship between the degree of left ventricular
function recovery and the duration of coronary ar-
tery disease. However, it is emphasized that a ear-
ly surgical intervention is the only treatment that
may stop the progressing heart damage [8].
A small study group and the single study cent-
er were limiting factors of our work. Moreover, our
study had the character of an observation with ran-
domized choice of patients. The discussed uncer-
tainties may be cleared out by a multicenter rand-
omized study.
Figure 4. Change in wall motion score (WMS) at 6 mon-
ths vs. WMS after dipyridamole administration.
Figure 3. Change in wall motion score (WMS) at 6 mon-
ths vs. WMS after dobutamine administration.
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Conclusions
1. Maximum left ventricular function improve-
ment in patients with left ventricular systolic
dysfunction who underwent surgical revascu-
larization was noted between 3 and 6 months
after the intervention.
2. Stress tests both with dobutamine and dipyri-
damole are characterized by a similar diagnos-
tic value for identifying left ventricular muscle
viability.
3. Left ventricular wall contractility index calcu-
lated during stress test proved to have the
highest prognostic value of contractility recov-
ery following coronary artery bypass grafting.
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